The direct answer
Yes. Iron supplements can damage the stomach lining. Whether they do — and how significantly — depends on three variables: the form of iron, the dose, and the pre-existing integrity of the gastric mucosa.
For most people taking a standard course at a standard dose, the damage is real but self-limiting — the normal mucosal repair cycle manages it adequately between doses. For people whose repair cycle is already compromised, the calculation changes.
How iron damages the mucosal surface
Ferrous sulphate and other non-chelated iron salts dissolve in gastric fluid and release free iron ions into direct contact with the gastric mucosa. These ions undergo the Fenton reaction — generating hydroxyl radicals that attack the lipid membranes of gastric epithelial cells.
At low concentrations, this causes reversible irritation. At higher concentrations, or with sustained exposure to a compromised epithelium, it causes cell death — erosion of the mucosal surface at the microscopic level. The stomach normally manages this through its EGFR/ERK repair pathway: damaged epithelial cells are replaced within hours by proliferating cells from the mucosal glands — in a healthy stomach.
The gastric epithelium has a remarkable capacity for rapid self-renewal — under normal conditions, surface cells are replaced within 72 hours. This capacity is dependent on intact EGFR/ERK signalling, which is suppressed by active mucosal inflammation.
When the damage outpaces repair
The mucosal repair cycle depends on the EGFR/ERK pathway — the same pathway that active gastric inflammation suppresses. When inflammation is present, the repair mechanisms are running below capacity. When iron's oxidative damage is applied to a system already struggling to repair itself, cumulative damage can accumulate faster than it resolves.
| Patient profile | Mucosal status | Iron damage risk |
|---|---|---|
| Healthy stomach, no prior gut symptoms | Intact mucosa, full repair capacity | LOW |
| Mild acidity, occasional reflux | Mildly irritated, mostly intact | LOW–MODERATE |
| Chronic acidity, undiagnosed gut issues | Likely some mucosal compromise | MODERATE |
| Diagnosed gastritis, no H. pylori testing | Thinned mucosa, reduced repair | MODERATE–HIGH |
| H. pylori positive, active gastritis | Actively damaged, repair impaired | HIGH |
The repair pathway and why it matters
The stomach's ability to recover from iron's oxidative damage relies on the EGFR/ERK pathway — a signalling cascade that triggers goblet cell regeneration and mucus synthesis in response to mucosal injury. H. pylori suppresses this pathway directly. Its inflammatory cascade activates NF-kB, which generates cytokines that both damage the mucosal surface and inhibit the EGFR/ERK repair response.
In this context, iron supplementation adds a second source of oxidative stress to a repair system already compromised. The practical result is a stomach that is slower to recover between doses, more vulnerable to each subsequent dose, and accumulating damage faster than it resolves it.
Switch to ferrous bisglycinate — substantially reduces Fenton reaction rate and hydroxyl radical generation.
Take with food — creates a physical buffer that reduces peak free ion concentration in the gastric environment.
Inhibit NF-kB — quercetin prevents the inflammatory amplification of iron's oxidative damage.
Activate EGFR/ERK repair — glabridin directly stimulates mucosal cell regeneration between doses, closing the repair deficit that long-term supplementation opens.
References
- Laine L et al. Gastric mucosal defense and cytoprotection. Gastroenterology. 2008;135(1):41–60. PMID 18549814. Establishes the EGFR/ERK pathway as the stomach's primary repair mechanism and defines how active inflammation suppresses it.
- Tolkien Z et al. Ferrous sulfate causes significant gastrointestinal side-effects. PLOS ONE. 2015;10(2). PMID 25700159. Meta-analysis establishing the differential mucosal damage rates between iron forms at equivalent elemental iron doses.
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. H. pylori's suppression of EGFR/ERK through NF-kB activation — the mechanism that creates high mucosal vulnerability to iron supplementation.
- Merlin Annie Raj, RD. TumGard India Gut Health Report 2026. Hugg Beverages Pvt. Ltd. 2026. tumgard.com/india-gut-health-report-2026. Source of the 86% clinically significant finding rate and 5.8% normal endoscopy rate in symptomatic Indians who were scoped (n=1,111).
The 86% significant finding rate is from TumGard's endoscopy sub-cohort — 1,111 symptomatic Indians who had previously undergone endoscopy and self-reported their results as part of the Digestion Analysis survey. This is a highly selected population (symptomatic, help-seeking, previously scoped) and should not be extrapolated as a general population prevalence. It is cited here to illustrate the prevalence of mucosal pathology in the population most likely to be simultaneously iron-supplementing.